Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Murugesan

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Indian Journal of Nephrology|December 3, 2015
Spontaneous nontraumatic subarachnoid hemorrhage without cerebrovascular malformations in a maintenance hemodialysis patientR Jayasurya, N Murugesan, R Kumar, et al.
Biochemistry|January 12, 1988
Chemistry of the alkali-labile lesion formed from iron(II) bleomycin and d(CGCTTTAAAGCG)H Sugiyama, C Xu, N Murugesan, et al.
The Journal of the Association of Physicians of India|October 14, 2008
Population based study of quality of diabetes care in southern IndiaA Ramachandran, S Mary, C K Sathish, et al.
Biochemistry|October 8, 1985
Analysis of products formed during bleomycin-mediated DNA degradationN Murugesan, C Xu, G M Ehrenfeld, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 9, 2003
Application of structure-metabolism relationships in the identification of a selective endothelin A antagonist, BMS-193884, with favourable pharmacokinetic propertiesW G Humphreys, M T Obermeier, J C Barrish, et al.
Journal of Medicinal Chemistry|February 4, 1994
The discovery of sulfonamide endothelin antagonists and the development of the orally active ETA antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulf onamideP D Stein, J T Hunt, D M Floyd, et al.
Journal of Medicinal Chemistry|August 24, 2000
Biphenylsulfonamide endothelin receptor antagonists. 2. Discovery of 4'-oxazolyl biphenylsulfonamides as a new class of potent, highly selective ET(A) antagonistsN Murugesan, Z Gu, P D Stein, et al.
Journal of Medicinal Chemistry|December 19, 1998
Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308)N Murugesan, Z Gu, P D Stein, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Indian Journal of Nephrology|December 3, 2015
Spontaneous nontraumatic subarachnoid hemorrhage without cerebrovascular malformations in a maintenance hemodialysis patientR Jayasurya, N Murugesan, R Kumar, et al.
Biochemistry|January 12, 1988
Chemistry of the alkali-labile lesion formed from iron(II) bleomycin and d(CGCTTTAAAGCG)H Sugiyama, C Xu, N Murugesan, et al.
The Journal of the Association of Physicians of India|October 14, 2008
Population based study of quality of diabetes care in southern IndiaA Ramachandran, S Mary, C K Sathish, et al.
Biochemistry|October 8, 1985
Analysis of products formed during bleomycin-mediated DNA degradationN Murugesan, C Xu, G M Ehrenfeld, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 9, 2003
Application of structure-metabolism relationships in the identification of a selective endothelin A antagonist, BMS-193884, with favourable pharmacokinetic propertiesW G Humphreys, M T Obermeier, J C Barrish, et al.
Journal of Medicinal Chemistry|February 4, 1994
The discovery of sulfonamide endothelin antagonists and the development of the orally active ETA antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulf onamideP D Stein, J T Hunt, D M Floyd, et al.
Journal of Medicinal Chemistry|August 24, 2000
Biphenylsulfonamide endothelin receptor antagonists. 2. Discovery of 4'-oxazolyl biphenylsulfonamides as a new class of potent, highly selective ET(A) antagonistsN Murugesan, Z Gu, P D Stein, et al.
Journal of Medicinal Chemistry|December 19, 1998
Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308)N Murugesan, Z Gu, P D Stein, et al.
Pageof 2